$115 Million is the total value of Madryn Asset Management, LP's 4 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | SOMALOGIC INC | $59,903,000 | -34.7% | 7,469,202 | -5.2% | 52.01% | -14.9% | |
ESTA | ESTABLISHMENT LABS HLDGS INC | $49,329,000 | -0.3% | 732,000 | 0.0% | 42.83% | +30.0% | |
SOMALOGIC INC | $3,536,000 | -42.0% | 838,099 | 0.0% | 3.07% | -24.3% | ||
VERO | VENUS CONCEPT INC | $2,403,000 | -15.9% | 1,680,598 | 0.0% | 2.09% | +9.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-05-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ESTABLISHMENT LABS HLDGS INC | 8 | Q3 2023 | 70.6% |
SOMALOGIC INC | 8 | Q3 2023 | 61.1% |
SOMALOGIC INC | 8 | Q3 2023 | 4.1% |
VENUS CONCEPT INC | 6 | Q1 2023 | 2.1% |
GREENBROOK TMS | 3 | Q3 2023 | 9.4% |
VENUS CONCEPT INC | 2 | Q3 2023 | 0.6% |
View Madryn Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Greenbrook TMS Inc. | July 25, 2022 | 2,631,578 | 8.2% |
Venus Concept Inc. | December 18, 2020 | 1,007,441 | 20.3% |
Aquestive Therapeutics, Inc. | December 01, 2020 | 1,530,717 | 4.2% |
View Madryn Asset Management, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-04-08 |
SC 13D/A | 2024-02-22 |
3 | 2024-01-11 |
DFAN14A | 2024-01-05 |
DFAN14A | 2024-01-04 |
DFAN14A | 2024-01-04 |
DFAN14A | 2024-01-03 |
DFAN14A | 2024-01-03 |
DFAN14A | 2024-01-02 |
DFAN14A | 2023-12-26 |
View Madryn Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.